Johnson & Johnson

Johnson & Johnson & Asbestos Exposure

Founded in 1886, Johnson & Johnson (J&J) grew into a global healthcare giant known for its wide range of consumer and pharmaceutical products. However, the company has also faced significant controversy and legal challenges, including allegations that its iconic baby powder contained asbestos.

In 1965, J&J acquired the assets of Eastern Magnesia Talc Co. and renamed the company Windsor Minerals, Inc. From 1967 to 1989, J&J directly owned and controlled Windsor. Talc sourced from the Windsor mine was later found to contain asbestos, a fact internal documents suggest the company knew as early as 1970.

Evidence of this knowledge appears in a 1969 letter from J&J Medical Director Dr. T.M. Thompson to company executive W. Ashton titled “Re: Alternate Domestic Talc Sources – Project Code #101.” In the letter, Thompson acknowledges the presence of tremolite asbestos in J&J talc products and discusses the potential risks it posed to consumers.

Exposure to asbestos-contaminated talc can occur through personal hygiene use, airborne talc dust, or secondary exposure, and has been linked to serious diseases. Despite internal concerns about contamination, J&J attorneys and officials reportedly testified under oath in a 1987 court case that the company had thoroughly tested Windsor talc and confirmed it was free of contaminants.

Concerns persisted decades later. In 2019, the U.S. Food and Drug Administration (FDA) detected asbestos in samples of Johnson’s Baby Powder, prompting J&J to recall more than 33,000 bottles from lot #22318RB. The company has since discontinued sales of talc-based baby powder in the United States and Canada.

Dangers of Asbestos-Contaminated Talcum Powder Products

Talc and asbestos are naturally occurring minerals that are often found near one another in the earth. As a result, it can be difficult to mine talc without contaminating it with asbestos. Talc deposits most commonly contain tremolite and anthophyllite, both highly toxic forms of asbestos.

When asbestos-containing materials are disturbed, they can release long, thin, needle-like fibers into the air. These fibers may be inhaled, swallowed, or deposited on the skin, where they can become embedded in body tissues. With talc products, exposure can occur through inhalation of airborne powder during normal use.

Repeated, long-term use of asbestos-contaminated talc products may lead to inflammation, scarring, and genetic damage. Over time, this exposure has been linked to serious and potentially life-threatening illnesses that can develop decades after initial contact.

Asbestos-related illnesses include:

• Mesothelioma
• Lung cancer
• Ovarian cancer
• Asbestosis
• Pleural thickening
• Pleural plaques
• Pleural effusions
• Other forms of cancer

Mesothelioma is the most severe and costly asbestos-related disease, with treatment potentially reaching $400,000 annually out-of-pocket for patients. This rare, often lethal cancer develops in the mesothelium, the protective lining around various internal organs.

Financial Compensation From Johnson & Johnson

Because Johnson & Johnson has not created an asbestos trust fund, victims seeking compensation for medical expenses, lost wages, and pain and suffering must pursue their claims through the courts.

Those pursuing legal compensation from J&J have two main options:

• ​​Personal injury lawsuit: Allows living victims of asbestos exposure to seek compensation for their losses.
• Wrongful death lawsuit: Allows the dependents or family members of deceased asbestos exposure victims to recover damages for the loss of their loved one.

Unfortunately, with asbestos-contaminated talc claims on the rise, J&J has resorted to several questionable legal strategies in an attempt to avoid responsibility to injured workers and consumers. One such strategy is called the “Texas Two-Step.”

During a Texas Two-Step, the at-fault company establishes an underfunded subsidiary to take responsibility for its asbestos or talc liabilities. The new entity that holds the liabilities then files for Chapter 11 bankruptcy to wipe out all claims against the parent company. This maneuver ends the litigation in exchange for establishing a trust fund. 

J&J first attempted a Texas Two-Step in 2021 through its subsidiary, LTL Management LLC, but the courts rejected it. They attempted the maneuver again with LTL in 2023 and were denied a second time. In 2025, they tried a third time with a new subsidiary, Red River Talc, but the courts rejected them again.

Johnson & Johnson Asbestos Lawsuits

Despite multiple attempts to shift responsibility, Johnson & Johnson continues to face a high volume of litigation, with over 90,000 cases filed as of early 2026. Most litigation surrounding J&J talc products centers on consumers and includes allegations like failure to warn and other product safety concerns. 

Multiple recent, high-verdict success stories give victims and their families reason to hope despite continuing pushback from J&J.

Landmark Historical Cases

• July 2018 (Inham): The court ordered Johnson & Johnson to pay $4.69 billion in damages ($4.14 billion in punitive damages and $550 million in compensatory damages) to 22 women and their families who alleged that asbestos found in the company’s talcum powder caused their ovarian cancer. Although the court later reduced the verdict to $2.1 billion, the case remains a turning point in J&J litigation.

Recent Major Verdicts (2025–2026)

• December 2025: A Baltimore jury awarded Cherie Craft a record-setting $1.5 billion in combined compensatory and punitive damages after finding that long-term use of J&J baby powder contributed to her diagnosis of peritoneal mesothelioma.
• October 2025: A California jury awarded $966 million to the family of Mae Moore following her death from mesothelioma. The lawsuit identified both J&J baby powder and Shower to Shower as contributing factors.
• December 2025: A California jury awarded Monica Kent and Deborah Schultz $40 million after determining that decades of using Johnson & Johnson’s talc-based baby powder contributed to both women developing ovarian cancer.

2016–2024 Talc Verdicts and Settlements

• February 2016: A St. Louis jury awarded Jacqueline Fox’s surviving family $72 million after they alleged her ovarian cancer was caused by long-term exposure to Johnson & Johnson’s talc products.
• October 2017: In a class-action lawsuit against J&J, evidence emerged indicating that the company had been aware of asbestos contamination in its talcum powder products, forcing it to pay $40 million to victims.
• April 2018: A New Jersey jury ordered Johnson & Johnson and Imerys Talc America to pay $80 million in punitive damages to Stephen Lanzo III.
• July 2023: A California jury awarded Emory Hernandez Valadez $18.8 million after determining that his pericardial mesothelioma, which develops in the tissue around the heart, was caused by exposure to asbestos from Johnson & Johnson products.
• April 2024: An Illinois jury awarded $45 million to the family of Theresa Garcia, finding her mesothelioma was caused by Johnson’s baby powder. Kenvue, a former consumer healthcare division of J&J, was included as a defendant in the case.
• May 2024: J&J announced a $6.48 billion settlement proposal in response to thousands of lawsuits claiming its baby powder causes cancer. In total, Johnson & Johnson has set aside $11 billion for asbestos talc settlements.

Asbestos-Containing Products Linked to Johnson & Johnson

Most asbestos claims against Johnson & Johnson are distinct because they originate from consumer exposure rather than industrial settings. The primary differences between consumer talc exposure and industrial asbestos exposure lie in the materials present, the concentration of asbestos, the individuals exposed, and the frequency of exposure.

Industrial asbestos exposure most often occurs in the workplace and is generally high intensity. On the other hand, in consumer talc cases, many victims are exposed to low doses for long periods. 

While some talc-related asbestos exposure may stem from the workplace (barbershops, salons, hospitals, etc.), much of it occurs in private spaces through personal use. 

Asbestos-contaminated J&J talc products:

• Johnson’s Baby Powder: Risks are explicitly tied to the talc-based version of the product. Newer, cornstarch-based formulations are not linked to asbestos. 
• Shower to Shower (Morning Fresh and Blossom Fresh): Marketed to adult women and heavily linked to ovarian cancer cases. Although J&J sold the brand to Valeant (now Bausch Health), it retains much of the liability for older asbestos claims.

Occupations and Individuals at Risk

While individuals with industrial ties to Johnson & Johnson, such as those involved in mining or packaging J&J talc products, represent some of the highest-risk exposure groups, the majority of Johnson & Johnson asbestos exposure claims are consumer-based.

These claims typically stem from private, in-home use or from individuals in professions like cosmetics or healthcare who regularly inhaled loose powder during their work.

High-risk groups include:

• Barbers 
• Caregivers
• Factory workers
• Hairdressers
• Miners
• Nurses
• Parents
• Salon employees

Get Help Today

If you or a loved one has developed an asbestos-related illness, such as mesothelioma or ovarian cancer, after using Johnson & Johnson products, you may have legal options. Evidence has shown that the company was aware of potential asbestos contamination in its talc products, yet continued to sell them.

Taking the first step toward justice and compensation can feel overwhelming, but acting quickly is important. There are strict time limits for filing a claim, and missing those deadlines may prevent you from recovering compensation.

Johnson & Johnson’s alleged failure to warn consumers has impacted countless individuals. If you’ve been affected, you don’t have to navigate this process alone. The Mesothelioma Fund, in partnership with Meirowitz & Wasserberg, offers experienced legal guidance, including a free case review and no-cost evaluation of your potential claim.

Contact us today to learn more about your options and take the first step toward pursuing compensation.